Clinical Trial Update: Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B Patients [Phase 4]

View source ↗

Summary

A Phase 4 comparative clinical trial evaluating antiviral activity and safety of an active drug in adults with chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Hepatitis B, Chronic | Phase 4 | Status: UNKNOWN